STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1338042

Aegerion Pharmaceuticals, Inc.
CIK 0001338042 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
89.8
composite ยท 3 signals ยท TRIGGERED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-01 ยท FY 2015-12-31 ยท TRIGGERED100.0

Earnings quality

Beneish M-Score 444.84 exceeds the -1.78 manipulation threshold
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2016-03-15) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": 444.837,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 0.523,
    "GMI": 1.163,
    "AQI": 1108.844,
    "SGI": 1.515,
    "DEPI": 0.76,
    "SGAI": 0.935,
    "LVGI": 2.044,
    "TATA": 0
  },
  "defaulted_to_neutral": [
    "TATA"
  ],
  "sloan_accruals": null,
  "inputs": {
    "revenue_t": 239887000,
    "revenue_t1": 158373000,
    "total_assets_t": 434198000,
    "net_income_t": -73339000,
    "cfo_t": null
  },
  "stale": false,
  "latest_filing_period": "2015-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/0001558370-16-004149-index.htm",
    "form": "10-K",
    "filed": "2016-03-15"
  }
}
P-13 ยท FY 2015-12-31 ยท TRIGGERED100.0

Zombie / distress

Zombie: interest coverage below 1.0x for 4 consecutive years
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2016-03-15) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2015-12-31": -1.637,
    "2014-12-31": -2.755,
    "2013-12-31": -137.631,
    "2012-12-31": -64.682
  },
  "consecutive_years_below_1": 4,
  "altman_z_double_prime": -1.742,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -45186000,
    "interest_expense_t": 27605000
  },
  "stale": false,
  "latest_filing_period": "2015-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/0001558370-16-004149-index.htm",
    "form": "10-K",
    "filed": "2016-03-15"
  }
}
P-12 ยท FY 2015-12-31 ยท CLEAN23.3

Restatement predictor

F-Score 0.70 โ€” at or below the population base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2016-03-15) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 0.7,
  "probability": 0.00259,
  "components": {
    "rsst": null,
    "drec": -0.0084,
    "dinv": 0.1162,
    "soft": 0.8402,
    "dcs": 0.5372,
    "droa": -0.0734,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2015-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1338042/000155837016004149/0001558370-16-004149-index.htm",
    "form": "10-K",
    "filed": "2016-03-15"
  }
}